Ischemic and bleeding outcomes after coronary artery bypass grafting among patients initially treated with a P2Y
Acute Coronary Syndrome
/ diagnostic imaging
Aged
Aged, 80 and over
Case-Control Studies
Clopidogrel
/ therapeutic use
Coronary Angiography
Coronary Artery Bypass
/ adverse effects
Female
Humans
Ischemia
/ pathology
Male
Middle Aged
Myocardial Infarction
/ epidemiology
Postoperative Hemorrhage
/ epidemiology
Prospective Studies
Purinergic P2Y Receptor Antagonists
/ therapeutic use
Stroke
/ epidemiology
Ticagrelor
/ therapeutic use
Time Factors
Treatment Outcome
Withholding Treatment
/ standards
Acute coronary syndrome
clopidogrel
coronary artery bypass surgery
myocardial infarction
ticagrelor
Journal
European heart journal. Acute cardiovascular care
ISSN: 2048-8734
Titre abrégé: Eur Heart J Acute Cardiovasc Care
Pays: England
ID NLM: 101591369
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
pubmed:
10
1
2018
medline:
19
8
2020
entrez:
10
1
2018
Statut:
ppublish
Résumé
Clinical outcomes in acute coronary syndrome patients treated with P2Y We examined clinical outcomes in acute coronary syndrome patients in relation to the timing of CABG following P2Y Among 508 patients (95 ticagrelor, 413 clopidogrel), the timing of CABG following P2Y CABG within 72 h after P2Y
Sections du résumé
BACKGROUND
BACKGROUND
Clinical outcomes in acute coronary syndrome patients treated with P2Y
METHODS
METHODS
We examined clinical outcomes in acute coronary syndrome patients in relation to the timing of CABG following P2Y
RESULTS
RESULTS
Among 508 patients (95 ticagrelor, 413 clopidogrel), the timing of CABG following P2Y
CONCLUSIONS
CONCLUSIONS
CABG within 72 h after P2Y
Identifiants
pubmed: 29313713
doi: 10.1177/2048872617740832
doi:
Substances chimiques
Purinergic P2Y Receptor Antagonists
0
Clopidogrel
A74586SNO7
Ticagrelor
GLH0314RVC
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM